Stereotactic body radiation therapy for low- to intermediate-risk prostate cancer has potential cost savings and may improve access to radiation, increase convenience, and boost quality of life.
Yair Lotan, MD
Advertisement
Articles by Yair Lotan, MD
Advertisement
Latest Updated Articles
- Cost-Effectiveness Analysis of SBRT Versus IMRT: An Emerging Initial Radiation Treatment Option for Organ-Confined Prostate Cancer
Published: May 9th 2012 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Medicare State Rankings Reveal Stark Differences in Access, Quality, and Affordability
2
In Its 50th Year, ESMO Comes to Berlin, a City Transformed
3
mRNA COVID-19 Vaccines Not Associated With Major Congenital Malformations During Pregnancy
4
Physical Activity, Vaccination May Protect Against Long COVID
5
